Background A prior in vitro study showed that idarubicin was the most cytotoxic agent for hepatocellular carcinoma (HCC) cell lines. Idarubicin-loaded beads for transarterial chemoembolization (TACE) were previously evaluated for the appropriate dose in a phase I dose-escalation study. Purpose To evaluate objective response rate (ORR), safety, and survival after TACE by using idarubicin-loaded beads for unresectable HCC.
View Article and Find Full Text PDFPurpose: To prospectively determine the accuracy of 3.0-T magnetic resonance (MR) enterography in the preoperative assessment of deep infiltrating endometriosis (DIE) lesions located in the bowel above the rectosigmoid junction.
Materials And Methods: Institutional review board approval for this study was obtained, and each patient gave written informed consent.
Objectives: There appears to be an increasing number of patients with aneurysm of the hepatic artery. We report a retrospective analysis of management schemes used in a single hospital unit over the last 14 years.
Patients And Methods: Clinical data on all patients with aneurysm of the hepatic artery, treated in Edouard-Herriot hospital (Lyon, France) from 1985 to 1999, were reviewed.